SCHEMBL1484601

SCHEMBL1484601

COc1ccc2[nH]c(-c3ccc(-n4cncn4)nc3)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
KDM4E B2RXH2 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
IDO1 P14902 1/20 0.43
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNT1 O60563 1/20 0.41
CDK9 P50750 1/20 0.41
ITK Q08881 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1422576 0.91 MAPT (0.41) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL1425121 0.85 MAPT (0.37) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL1484245 0.85 KDM4E (0.41) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL1483994 0.85 CYP1A2 (0.37) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL1484070 0.84 CYP1A1 (0.45) MAPTKDM4EIDO1ALDH1A1GLA
SCHEMBL1484034 0.83 IDO1 (0.48) KDM4EIDO1ALDH1A1PIM1
SCHEMBL1424611 0.80 MAPT (0.49) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL1423141 0.80 NPC1 (0.49) MAPTKDM4ENPC1RAB9AMEN1
SCHEMBL12829963 0.79 CYP2D6 (0.47) MAPTKDM4ERAB9AHPGDSMN1; SMN2
SCHEMBL1424267 0.79 PIM1 (0.39) MAPTKDM4EIDO1ITKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
WO-2009155024-A1 NOVEL SUBSTITUTED INDOLES MERCK & CO., INC. (US) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 MAPT 8/4885KDM4E 1666/4885NPC1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.